• Home
• ltk asia
• The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung

5 (200) · $ 11.50 · In stock

Tadashi Manabe MD, PhD on X: A whole new oncogenic driver in non

EGFR exon 20 insertion mutations and ERBB2 mutations in lung

IJMS, Free Full-Text

Combinatorial tumor suppressor inactivation efficiently initiates

Full article: The CLIP1–LTK fusion: anew oncogenic driver in non

Genotype-phenotype mapping of a patient-derived lung cancer

Rare molecular subtypes of lung cancer

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung

壹生资讯-它是否能成为肺癌靶向治疗的下一个新靶点？

Recombinant Anti-LTK antibody [EPR5175(2)] (ab129155)

Lung Cancer Program - DF/HCC

The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung